Form 4 · Filed Jun 2, 2026, 11:00 PM UTC
DNTH/Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat — EVP, Head of R&D
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
11 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | M | other | 3,998 | $8 | $33,743 | 7,998 |
| Jun 1, 2026 | M | other | 6,908 | $18 | $123,515 | 14,906 |
| Jun 1, 2026 | M | other | 6,249 | $22 | $136,041 | 21,155 |
| Jun 1, 2026 | M | other | 9,375 | $22 | $206,906 | 30,530 |
| Jun 1, 2026 | S | sell | 5,428 | $90 | $487,000 | 25,102 |
| Jun 1, 2026 | S | sell | 16,943 | $91 | $1,537,069 | 8,159 |
| Jun 1, 2026 | S | sell | 4,159 | $91 | $380,008 | 4,000 |
| Jun 1, 2026 | M | other | 3,998 | — | — | 0 |
| Jun 1, 2026 | M | other | 6,908 | — | — | 64,276 |
| Jun 1, 2026 | M | other | 6,249 | — | — | 47,925 |
| Jun 1, 2026 | M | other | 9,375 | — | — | 96,875 |
Source: SEC EDGAR raw filing ↗ · Accession 0001992260-26-000006